SG49692A1 - Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis - Google Patents

Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis

Info

Publication number
SG49692A1
SG49692A1 SG1996004119A SG1996004119A SG49692A1 SG 49692 A1 SG49692 A1 SG 49692A1 SG 1996004119 A SG1996004119 A SG 1996004119A SG 1996004119 A SG1996004119 A SG 1996004119A SG 49692 A1 SG49692 A1 SG 49692A1
Authority
SG
Singapore
Prior art keywords
group
oral
treatment
topical administration
leishmaniasis
Prior art date
Application number
SG1996004119A
Other languages
English (en)
Inventor
Medica Ag Asta
Max-Planck-Gesellschaft
Original Assignee
Medica Ag Asta
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medica Ag Asta, Max Planck Gesellschaft filed Critical Medica Ag Asta
Publication of SG49692A1 publication Critical patent/SG49692A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
SG1996004119A 1991-09-27 1992-09-24 Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis SG49692A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4132344A DE4132344A1 (de) 1991-09-27 1991-09-27 Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis

Publications (1)

Publication Number Publication Date
SG49692A1 true SG49692A1 (en) 1998-06-15

Family

ID=6441697

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004119A SG49692A1 (en) 1991-09-27 1992-09-24 Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis

Country Status (13)

Country Link
US (1) US5980915A (da)
EP (1) EP0534445B1 (da)
JP (2) JP3587862B2 (da)
KR (2) KR100270255B1 (da)
AT (1) ATE177950T1 (da)
BR (1) BR9203768A (da)
DE (2) DE4132344A1 (da)
DK (1) DK0534445T3 (da)
ES (1) ES2132101T3 (da)
GR (1) GR3030016T3 (da)
HK (1) HK1004472A1 (da)
MX (1) MX9205466A (da)
SG (1) SG49692A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254879B1 (en) * 1991-09-27 2001-07-03 Max-Planck-Gessellschaft zun Förderung der Wissenschaften e.V. Methods of treating protozoal diseases
US5681829A (en) * 1992-10-08 1997-10-28 Shaman Pharmaceuticals, Inc. Class of phosphocholine derivatives having antifungal activity
DE4305554C2 (de) * 1992-12-18 2000-03-02 Rhone Poulenc Rorer Gmbh Phospholipidische Zusammensetzung
PT1051159E (pt) * 1998-01-22 2002-09-30 Zentaris Ag Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose
DE19835611A1 (de) * 1998-08-06 2000-02-10 Max Planck Gesellschaft Neuartige Phospholipide mit synthetischen, ungesättigten Alkyl- und Acylketten
DE10015814A1 (de) * 2000-03-30 2001-10-11 Max Planck Gesellschaft Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung
DE10025122A1 (de) * 2000-05-20 2001-11-22 Beiersdorf Ag Kombinationen von Clycerinmonoalkylethern und Fettsäreglyceriden
DE10025124B4 (de) * 2000-05-20 2015-07-16 Beiersdorf Ag Kombinationen von Glycerinmonoalkylethern und Aryl-substituierten Alkoholen
BG64968B1 (bg) * 2000-08-07 2006-11-30 Asta Medica Aktiengesellschaft Твърди фармацевтични състави, съдържащи милтефозин за орално приложение при лечението на leishmaniasis
US7887817B2 (en) 2002-01-25 2011-02-15 Aeterna Zentaris Gmbh Process for preventing protozoal diseases
DE10203195A1 (de) * 2002-01-25 2003-08-07 Zentaris Ag Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen
BR0315840A (pt) * 2002-10-30 2005-09-27 Makscientific Corp Fosfolipìdeos de anel substituìdo anti-protozoários
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
UA99434C2 (ru) * 2005-12-19 2012-08-27 Аетерна Центаріс Гмбх Применение производных алкилфосфолипидов со сниженной цитотоксичностью
JP5232009B2 (ja) * 2005-12-19 2013-07-10 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減された細胞毒性を有するアルキルリン脂質誘導体並びにそれらの使用
DE102007014375A1 (de) 2007-03-26 2008-10-02 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Oleylphosphocholin
NZ597560A (en) * 2009-07-09 2013-05-31 Paul Meng Liquid pharmaceutical form of alkylphosphocholine and method of preparing same
US9358244B2 (en) 2010-11-22 2016-06-07 Oblita Therapeutics Bvba Solid dosage forms of oleyl phosphocholine
EA202092369A1 (ru) * 2018-04-10 2021-01-26 Селлектар Байосайенсиз, Инк. Конъюгаты фосфолипид-флаваглин и способы их применения для целенаправленной терапии рака

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
IE59777B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicaments
US5087721A (en) * 1987-10-23 1992-02-11 The University Of Michigan Radioiodinated phosphate esters
WO1989010370A1 (en) * 1988-04-19 1989-11-02 Cl-Pharma Aktiengesellschaft New alkylphosphono- and phosphoserines, method for preparing them, and pharmaceutical substances containing them

Also Published As

Publication number Publication date
JP2004315540A (ja) 2004-11-11
DE4132344A1 (de) 1993-04-01
HK1004472A1 (en) 1998-11-27
JP3587862B2 (ja) 2004-11-10
ATE177950T1 (de) 1999-04-15
KR100270255B1 (ko) 2002-09-04
BR9203768A (pt) 1993-04-20
ES2132101T3 (es) 1999-08-16
GR3030016T3 (en) 1999-07-30
KR100283783B1 (ko) 2001-02-15
KR930005622A (ko) 1993-04-20
JPH06263643A (ja) 1994-09-20
DK0534445T3 (da) 1999-10-18
EP0534445A1 (de) 1993-03-31
DE59209663D1 (de) 1999-04-29
US5980915A (en) 1999-11-09
MX9205466A (es) 1993-05-01
EP0534445B1 (de) 1999-03-24

Similar Documents

Publication Publication Date Title
SG49692A1 (en) Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis
CZ158695A3 (en) Pyrazolopyrimidine compounds as such and for treating diseases and pharmaceutical preparations based thereon
DE69201948T2 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
GR3035587T3 (en) Thienobenzodiazepine derivatives for treatment of CNS disorders.
HUT73433A (en) Process for preparing pharmaceutical compositions containing riluzole for treating aids-related neural disorders
GR3019957T3 (en) Derivatives of substituted cyclohexane, their process of preparation and their application with the treatment of diseases
RU94045278A (ru) Применение 2-фенил-3-ароилбензтиофенов для ингибирования вазомоторных симптомов и сопутствующих психологических нарушений, ассоциированных с постклимактерическим синдромом
HUT46536A (en) Process for producing antianxietive pharmaceutical compositions
HU9200335D0 (en) Medical products with human interleukin-2 content
HUT66022A (en) Vitamin d3 analogs and pharmaceutical compositions containing them and process for production thereof
YU66900A (sh) Derivati higromicina a
HUT49283A (en) Process for production of medical compositions applicable for treatment of peptical ulcer
MX9707596A (es) Benzamidas, el uso de las mismas, composiciones que las contienen, para el tratamiento del transtorno neurodegenerativo, y procedimiento para la preparacion del mismo.
IT1256178B (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
GB8823605D0 (en) Therapeutic agents
HUT48265A (en) Process for producing phosphorous-containing 2-isoxazolines and isoxazoles and pharmaceutical compositions containing them or theyr salts as active components
DE69818060D1 (de) Polyhydroxyalkylpyrazine derivate, deren herstellung,diese enthaltende arzneimitteln
EP0551844A3 (da)
HU9203052D0 (en) Method for treatment of hypertension
MXPA02011966A (es) Derivados de higromicina a para el el tratamiento de infecciones bacterianas y por protozoarios.
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
IE781718L (en) Imidazole derivatives
IT1248558B (it) Derivati della fisovenina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IL109227A0 (en) Leustroducsin h, pharmaceutical composition containing the same, and processes for the preparation thereof